Health Section: Stop loss Market conditions with Jon Forster

<p class="MsoNormal" style="background: white;"><span style= "font-size: 12.0pt; font-family: 'Calibri Light',sans-serif; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; color: black; mso-color-alt: windowtext;"> Dave Dillon welcomes guest Jon Forster,</span> <span style= "font-size: 12.0pt; font-family: 'Calibri Light',sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; color: black;"> former executive for Medical Risk Managers for a discussion about current Market conditions of the stop loss industry. We’ll cover current stop loss products in the market, the pipeline of cell and gene therapy, and new underwriting uses of AI.  Jon has 20 years’ experience in actuarial leadership positions and recently moved to work full time with the Society of Actuaries to accelerate  professional development offerings.  </span></p>